Buenos Aires - Delayed Quote ARS
Johnson & Johnson (JNJ.BA)
12,425.00
+175.00
+(1.43%)
As of 3:37:04 PM GMT-3. Market Open.
Research Analysis
Earnings Estimate
Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
No. of Analysts | -- | -- | -- | -- |
Avg. Estimate | 0 | 0 | 0 | 0 |
Low Estimate | 0 | 0 | 0 | 0 |
High Estimate | 0 | 0 | 0 | 0 |
Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
No. of Analysts | 15 | 15 | 19 | 21 |
Avg. Estimate | 22.85B | 23.1B | 91.32B | 94.83B |
Low Estimate | 22.51B | 22.91B | 90.82B | 93.02B |
High Estimate | 23.09B | 23.24B | 91.87B | 96.6B |
Year Ago Sales | 22.45B | 22.47B | 88.82B | 91.32B |
Sales Growth (year/est) | 1.78% | 2.80% | 2.81% | 3.85% |
EPS Trend
Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
Current Estimate | 0 | 0 | 0 | 0 |
7 Days Ago | 0 | 0 | 0 | 0 |
30 Days Ago | 0 | 0 | 0 | 0 |
60 Days Ago | 0 | 0 | 0 | 0 |
90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
Up Last 7 Days | -- | -- | -- | -- |
Up Last 30 Days | -- | -- | -- | -- |
Down Last 7 Days | -- | -- | -- | -- |
Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
Current Qtr. | Next Qtr. | Current Year | Next Year | |
---|---|---|---|---|
JNJ.BA | -- | -- | -- | -- |
S&P 500 | 6.94% | 4.52% | 8.32% | 14.18% |
Related Tickers
AZN.BA AstraZeneca PLC
41,825.00
+3.14%
GS71.F GSK plc
16.58
+2.66%
MRK.BA Merck & Co., Inc.
18,900.00
+1.34%
PFE.BA Pfizer Inc.
6,850.00
+3.47%
GLAXF GSK plc
18.46
+6.58%
LLY.MX Eli Lilly and Company
16,715.00
+3.82%
LLY0.DU Eli Lilly and Co
19.60
+2.08%
GRF.MC Grifols, S.A.
8.45
+0.64%
NOVN.SW Novartis AG
92.00
+1.21%
BAYN.DE Bayer Aktiengesellschaft
22.48
+1.70%